Bruker Corporation (BRKR) stock analysis
BRKR · Bruker Corporation
Latest recorded price: USD 60.62
Model-estimated fair value: USD 22.57. This assumption-based estimate is for general research and is not investment advice.
Sector and industry: Healthcare · Medical Devices
At $60.62, BRKR trades 168.6% above the model's base-case value of $22.57. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $16.17 in the conservative case and $30.13 in the optimistic case, with a valuation confidence score of 75/100. About 73% of the value comes from the terminal value, so the result is sensitive to long-term growth and discount-rate assumptions. Fiscal 2025 figures: revenue growth 10.7%, free cash flow margin 1.3%, ROIC 1.3%. The model flags 1 risk signal for this company.
Similar companies in Healthcare
- Boston Scientific Corporation Common Stock (BSX)
- CONMED Corporation Common Stock (CNMD)
- DexCom, Inc. - Common Stock (DXCM)
- Enovis Corporation (ENOV)
- Establishment Labs Holdings Inc. (ESTA)
- Edwards Lifesciences Corporation (EW)
- GE HealthCare Technologies Inc. - Common Stock (GEHC)
- Glaukos Corporation Common Stock (GKOS)